Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -68.1133.8294.6045.00-24.35

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is -68.11 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00
Mar2020-24.35

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45
Positive
Mar2020 -24.35 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹157.6 Cr -4% -3.7% -29% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,498.0 Cr 1.9% -2.1% -6.2% Stock Analytics
DIVIS LABORATORIES ₹165,838.0 Cr 2.7% -5.6% 25.2% Stock Analytics
CIPLA ₹129,330.0 Cr 3.4% 7.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,235.0 Cr 0.6% 4.4% 9.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,211.0 Cr 3.2% 1.6% -8.4% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-4%

-3.7%

-29%

SENSEX

0.5%

-1.3%

0.9%


You may also like the below Video Courses